Related content

Phase I/II trial of weekly docetaxel and concomitant radiotherapy for squamous cell carcinoma of the head and neck

By Fujii Masato   Tsukuda Mamoru   Satake Bunsuke   Kubota Akira   Kida Akinori   Kohno Naoyuki   Okami Kenji   Inuyama Yukio  

International Journal of Clinical Oncology, Vol. 9, Iss. 2, 2004-04 ,pp. : 107-112

Springer Publishing Company

Access to resources Recommend Favorite

Weekly docetaxel and concomitant boost radiotherapy for non-small cell lung cancer. A phase I/II dose escalation trial

By Koukourakis M.I.   Kourousis C.   Kamilaki M.   Koukouraki S.   Giatromanolaki A.   Kakolyris S.   Kotsakis A.   Androulakis N.   Bahlitzanakis N.   Georgoulias V.  

European Journal of Cancer, Vol. 34, Iss. 6, 1998-05 ,pp. : 838-844

Elsevier

Access to resources Recommend Favorite

Mature Results of a Phase II Trial of Concomitant Cisplatin/Pelvic Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Cervix

By Fields A.L.   Anderson P.S.   Goldberg G.L.   Wadler S.   Beitler J.   Sood B.   Runowicz C.D.  

Gynecologic Oncology, Vol. 61, Iss. 3, 1996-06 ,pp. : 416-422

Academic Press

Access to resources Recommend Favorite

Induction therapy with cetuximab plus docetaxel, cisplatin, and 5‐fluorouracil (ETPF) in patients with resectable nonmetastatic stage III or IV squamous cell carcinoma of the oropharynx. A GERCOR phase II ECHO‐07 study

By  

Cancer Medicine, Vol. 4, Iss. 5, 2015-05 ,pp. : 721-731

John Wiley & Sons Inc

Access to resources Recommend Favorite

Neoadjuvant Chemotherapy Plus Conventional Radiotherapy or Accelerated Hyperfractionation in Stage III and IV Nasopharyngeal Carcinoma - A Phase II Study

By El-Weshi Amr   Khafaga Yasser   Allam Ayman   Mosseri Veronique   Ibrahim Ezzeldin   El-Serafi Mostafa   El-Badawi Samy  

Acta Oncologica, Vol. 40, Iss. 5, 2001-09 ,pp. : 574-581

Informa Healthcare

Access to resources Recommend Favorite